Abstract
Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders among females. Although there is a diverse range of causes that are not entirely understood, recent studies indicate the potential role of myo-inositol in the pathophysiology of PCOS: i) insulin resistance in PCOS women can be attributed to a deficiency of myo-inositol’s intracellular metabolites, D-chiro-inositol (DCI) and inositol-phosphoglycan (IPG), mediators of insulin action; ii) PCOS patients have a higher urinary clearance of DCI; and iii) DCI functions as an intracellular messenger in mammalian oocytes, playing a role in the follicular milieu, meiotic resumption, and oocyte maturation. Recently, myo-inositol has been used in PCOS patients more and more as a natural insulin sensitizer and until today, there are more than 70 clinical trials on determining the effect of myo-inositol and/or DCI as insulin-sensitizing compound in PCOS women.
Keywords: AGE, anovulation, BMI, chiro-inositol, DCI, inosituria, oligoovulation, PCOS, sorbitol, Stein-Leventhal.
Related Books
Advances in Physicochemical Properties of Biopolymers (Part 1)
Advances in Physicochemical Properties of Biopolymers (Part 2)
Biochemical Mechanisms of Aluminium Induced Neurological Disorders
Biochemistry: Fundamentals and Bioenergetics
Biology and Chemistry of Beta Glucan Volume Title: Beta-Glucan, Structure, Chemistry and Specific Application
Biology and Chemistry of Beta Glucan Vol: 1 Beta Glucans - Mechanisms of Action
Cutting Edge Techniques in Biophysics, Biochemistry and Cell Biology: From Principle to Applications
Essential Techniques for Medical and Life Scientists: A Guide to Contemporary Methods and Current Applications with the Protocols: Part I
Essential Techniques for Medical and Life Scientists: A Guide to Contemporary Methods and Current Applications- Part II
Evaluation of Cellular Processes by In Vitro Assays